PETS
PetMed Express, Inc.
$2.28
-0.87%
2026-05-08
About PetMed Express, Inc.
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Key Fundamentals
Forward P/E
-76.33
EPS (TTM)
$-3.11
ROE
-100.6%
Revenue Growth (YoY)
-21.7%
Profit Margin
-34.7%
Debt/Equity
1.99
Price/Book
1.49
Beta
0.79
Market Cap
$49.0M
Avg Volume (10D)
58K
Recent Breakout Signals
No recent breakout signals detected for PETS.
Recent Price Range (60 Days)
60D High
$3.23
60D Low
$2.19
Avg Volume
88K
Latest Close
$2.28
Get breakout alerts for PETS
Sign up for Breakout Scanner to receive daily notifications when PETS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
PetMed Express, Inc. (PETS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PETS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PETS operates in the Healthcare sector within the Pharmaceutical Retailers industry. Data is provided for informational purposes only and does not constitute financial advice.